July 21, 2014 Synthetic Biologics' Academic Collaborator to Present Novel Monoclonal Antibody Combination for Treating Whooping Cough (Pertussis) at Gordon Research Conference
June 30, 2014 Synthetic Biologics Forms Clinical Advisory Board to Support Novel C. difficile Preventative Program
June 25, 2014 Synthetic Biologics Reports that Licensor Cedars-Sinai Finds Eradication of Gut Methane Improves Insulin Sensitivity and Lipid Profiles in Study of Pre-Diabetic, Obese Patients
June 10, 2014 Synthetic Biologics and Enterome Bioscience Collaborate on Microbiome Research to Support Synthetic Biologics' C. difficile Program
May 15, 2014 Synthetic Biologics Reports First Quarter 2014 Financial Results and Operational Highlights
May 8, 2014 Synthetic Biologics Announces Recent International Patents that Bolster its C. difficile Program
April 30, 2014 Synthetic Biologics to Discuss Phase II Results of Oral Estriol Candidate Trimesta™ for Relapsing-Remitting Multiple Sclerosis in Women
April 29, 2014 Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for Relapsing-Remitting Multiple Sclerosis
